About Macrodeep
New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

Il rapporto

Notizie verificate su finanziamenti, sedi centrali e leadership delle aziende più innovative al mondo

8 report e oltre

Aggiornato quotidianamente con le ultime intelligence di mercato
Fundraising
Abcuro

Abcuro Raises $66M Series D for Inclusion Body Myositis Trial

Abcuro raised a $66 million Series D led by New Leaf Venture Partners to fund a new potentially registrational study of ulviprubart in inclusion body myositis.

SalesTools Research
Aug 18, 2026
2 min read•$66M
Fundraising
Claris Bio

Claris Bio Raises $118M Series B for Limbal Stem Cell Deficiency Therapy

Claris Bio closed a $118 million Series B co-led by Samsara Biocapital and Catalio Capital Management to fund trials and a planned pivotal program in limbal stem cell deficiency.

SalesTools Research
Jul 28, 2026
2 min read•$118M
Fundraising
Samsara

Samsara Raises $300M in Series G

Samsara, a Logistics company based in San Francisco, CA, has raised $300M in Series G at a $10.8B valuation led by Tiger Global, Andreessen Horowitz, General Catalyst.

Fundraising News Team
Oct 15, 2025
0 min read
IoT
Samsara

Samsara raises $300M Series F at $5.4B valuation

Samsara raises $300M in Series F at $5.4B valuation. Connected operations cloud platform...

Editorial Team
Sep 15, 2020
0 min read•$300M
IoT
Samsara

Samsara Headquarters - Office Location & Address

Discover Samsara's headquarters at 1 De Haro St, San Francisco, CA 94107. IoT platform for operations. Learn about the office facilities and work environment.

Editorial Team
Oct 5, 2025
0 min read
Fundraising
Graphite Bio

Graphite Bio Raises $238M in Series B

Graphite Bio, a Biotech company based in 279 East Grand Avenue, South San Francisco, CA 94080, has raised $238M in Series B at a $1B valuation led by ARCH Venture Partners, Vida Ventures, Norwest Venture Partners, Samsara BioCapital.

Fundraising News Team
Apr 28, 2024
0 min read
HealthTech
Normunity

Normunity raises $75M Series B at $500M valuation

Normunity raises $75M in Series B at $500M valuation. T cell engager therapies...

Editorial Team
Jan 1, 2025
0 min read•$75M
Biotech
Graphite Bio

Graphite Bio raises $238M Series B at $1B valuation

Graphite Bio raises $238M in Series B at $1B valuation. Precision genetic medicines...

Editorial Team
Apr 28, 2024
0 min read•$238M
Pagina 1

Visualizzazione di 8 report • Pagina 1 • Categoria: all

Rimani avanti rispetto al mercato

Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.